Yoshihiro_Takai_5.jpg

高井 良尋

南東北硼中子捕獲治療研究中心主任

  • 現職

    • 南東北硼中子捕獲治療研究中心主任
    • 弘前大學醫學部名譽教授
  • 學歷

    • 1976

      福島縣立醫科大學醫學部醫學士

    • 1983

      東京大學醫學系研究科放射線基礎醫學博士

  • 專科醫師資格

    • 日本放射線醫學會專家及放射線治療認證指導醫師
    • 日本環境省原子力規制委員會第一種輻射防護證照督導
  • 經歷

    • 1976-1977

      東京大學醫學部放射線學科講師

    • 1977-1979

      東京大學醫學部放射線學與生物醫學工程學科講師

    • 1983-1984

      東北大學醫學部放射線學科講師

    • 1986-1996

      東北大學醫學部放射線學科資深講師

    • 1996-2005

      東北大學醫學部放射線學科副教授

    • 2005-2008

      東北大學醫學部保健學科臨床放射技術學教授

    • 2008-2010

      東北大學醫學系研究科保健學科放射治療學教授

    • 2010-2016

      弘前大學大學院醫學研究科放射線學科與放射腫瘤學科教授及主任

    • 2006-至今

      南東北硼中子捕獲治療研究中心主任

  • 專長

    • 惡性(癌)腫瘤放射治療
    • 硼中子捕獲治療
    • 放射腫瘤學
    • 放射生物學
  • 醫學會

    • 1993-1996

      日本放射線醫學會腫瘤學委員會委員

    • 1996-1997

      日本放射線醫學會教育委員會委員及健康保險委員會委員

    • 2000-2016

      日本放射線醫學會代表

    • 2004-2007

      日本食道學會評議員

    • 2007-2014

      日本放射腫瘤學會理事

    • 2007-2010

      日本放射腫瘤學會病患安全委員會委員長及調查研究委員會委員長

    • 2012-2014

      日本放射腫瘤學會編輯委員會委員長

    • 2013年10月18日至20日

      第26屆日本放射腫瘤學會學術年會主席 (日本青森)

    • 2014年11月4日至7日

      日本教育文化體育科技省2014亞洲核能論壇協調者

    • 2017年9月29日至30日

      第14屆日本中子捕獲治療學會學術年會主席 (日本郡山)

  • 精選學術論文

    • Masahiko Aoki, Mariko Sato, Katsumi Hirose, Hiroyoshi Akimoto, Hideo Kawaguchi, Yoshiomi Hatayama, Shuichi Ono, Yoshihiro Takai, Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.  Radiation oncology (London, England) 2015; 10: 99-1-99-8
    • Xiaoyong Zhang, Noriyasu Homma, Kei Ichiji, Yoshihiro Takai, Makoto Yoshizawa Tracking tumor boundary in MV-EPID images without implanted markers: A feasibility study.  Medical physics  2015; 42 (5): 2510-2510
    • Takaaki Beppu, Toshiaki Sasaki, Kazunori Terasaki, Hiroaki Saura, Hideki Mtsuura, Kuniaki Ogasawara, Makoto Sasaki, Shigeru Ehara, Ren Iwata, Yoshihiro Takai, High-uptake areas on positron emission tomography with the hypoxic radiotracer (18)F-FRP170 in glioblastomas include regions retaining proliferative activity under hypoxia. Annals of Nuclear Medicine 2015; 29:336-341
    • Hiroaki Saura, Kuniaki Ogasawara, Takaaki Beppu, Koji Yoshida, Masakazu Kobayashi, Kenji Yoshida, Kazunori Terasaki, Yoshihiro Takai, Akira Ogawa, Hypoxic viable tissue in human chronic cerebral ischemia because of unilateral major cerebral artery stenoocclusive disease.  Stroke 2015; 46:1250-1256
    • Mariko Sato, Katsumi Hirose, Ikuo Kashiwakura, Masahiko Aoki, Hideo Kawaguchi, Yoshiomi Hatayama, Hiroyoshi Akimoto, Yuichiro Narita, Yoshihiro Takai, LW6, a hypoxia inducible factor 1 inhibitor, selectively induces apoptosis in hypoxic cells through depolarization of mitochondria in A549 human lung cancer cells. Molecular medicine reports 2015; 12: 3462-3468
    • K Hirose, M Sato, M Aoki, H Kawaguchi, H Akimoto, Y Hatayama, F Komai, M Sohma, H Obara, M Suzuki, Y Takai, SU-E-J-40: Improving Uncertainty of Prostate Positioning by Using Implanted Fiducial Marker-Based Hybrid Evaluation Combined with KV Portal Imaging and CBCT for Prostate IMRT. Medical physics 2015; 42 (6): 3272-3272
    • X Zhang, N Homma, Y Takai, K Ichiji, N Sugita, M Abe, M Yoshizawa, WE-AB-303-02: A Real-Time Homography-Based Algorithm for Markerless Deformable Lung Tumor Motion Tracking Using KV X-Ray Fluoroscopy. Medical physics 2015; 42 (6): 3656-3656
    • Y. Hatayama, T. Nakamura, M. Suzuki, Y. Azami, T. Ono, H. Yamaguchi, Y. Hayashi, I. Tsukiyama, M. Hareyama, Y. Kikuchi, Y. Takai, Preliminary results of proton-beam therapy for stage III non-small-cell lung cancer Current Oncology. 2015; 22(5): e370-5
    • Hatayama Y, Nakamura T, Suzuki M, Azami Y, Ono T, Yabuuchi T, Hayashi Y, Kimura K, Hirose K, Wada H, Hareyama M, Kikuchi Y, Takai Y. Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2015; pii: S1525-7304(15)00277-6.
    • Aoki M, Hatayama Y, Kawaguchi H, Hirose K, Sato M, Akimoto H, Fujioka I, Ono S, Takai Y, Stereotactic body radiotherapy for lung metastases as oligo-recurrence: A single institutional study J Radiat Res 2016; 57:55-61
    • Aoki M, Hatayama Y, Kawaguchi H, Hirose K, Sato M, Akimoto H, Fujioka I, Ono S, Tsushima E, Takai Y., Clinical outcome of stereotactic body radiotherapy for primary and oligometastatic lung tumors: a single institutional study with almost uniform dose with different five treatment schedules. Radiat Oncol. 2016; 20:11(1):5
    • Aoki M, Hirose K, Sato M, Akimoto H, Kawaguchi H, Hatayama Y, Fujioka I, Tanaka M, Ono S, Takai Y., Prognostic impact of average iodine density assessed by dual-energy spectral imaging for predicting lung tumor recurrence after stereotactic body radiotherapy. J Radiat Res. 2016; pii: rrv100.
    • Wada Y, Hirose K, Harada T, Sato M, Watanabe T, Anbai A, Hashimoto M, Takai Y. Impact of oxygen status on 10B-BPA uptake into human glioblastoma cells, referring to significance in boron neutron capture therapy. J Radiat Res. 2018; 59:122-128.
    • Hirose K, Sato M, Hatayama Y, Kawaguchi H, Komai F, Sohma M, Obara H, Suzuki M, Tanaka M, Fujioka I, Ichise K, Takai Y, Aoki M., The potential failure risk of the cone-beam computed tomography-based planning target volume margin definition for prostate image-guided radiotherapy based on a prospective single-institutional hybrid analysis. Radiat Oncol. 2018 Jun 7;13(1):106. doi: 10.1186/s13014-018-1043-9.
友善列印版本